Patents by Inventor Elaine Benaksas Schwartz

Elaine Benaksas Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • R-NSAID esters and their use
    Patent number: 7074826
    Abstract: The present invention concerns esters of R-enantiomers of a non-steroidal anti-inflammatory drug, which is substantially free from the S-enantiomer. The compounds of the invention may be used in treating a disease or illness in a mammal. To this end, a composition comprising a compound mentioned above, or a pharmaceutically acceptable salt thereof where salt formation occurs, is administered to the mammal in an amount sufficient to elicit a chemopreventative effect or a chemoprotective effect or a therapeutic effect or a prophylactic effect.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: July 11, 2006
    Assignee: Encore Pharmaceuticals, Inc.
    Inventors: William J. Wechter, Elaine Benaksas Schwartz
  • Methods for screening compounds for use in the treatment of disease
    Publication number: 20040152146
    Abstract: Methods are disclosed for screening compounds for use in the treatment of, or the identification of a clinical or biological target for, a disease. The method comprises determining the ability of the compound to influence interactions involving alpha-methylacyl-CoA racemase.
    Type: Application
    Filed: December 11, 2003
    Publication date: August 5, 2004
    Inventors: William J. Wechter, E. David Murray, Elaine Benaksas Schwartz, Israel Gutierrez, David D. Quiggle
  • Therapeutically active compounds
    Publication number: 20040152777
    Abstract: The present invention concerns methods for treating a disease or illness in a mammal, the method comprising administering to the mammal a composition comprising a compound in an amount effective to elicit a chemopreventative effect or a therapeutic effect or a prophylactic effect or a chemoprotective effect, the compound having the formula:
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Inventors: William J. Wechter, Israel Gutierrez, Elaine Benaksas Schwartz, E. David Murray
  • Fat substitutes
    Publication number: 20040151758
    Abstract: The present invention concerns fat substitutes that are compounds, which are fatty acids whose yield energy from beta-oxidation is sufficiently low so that the compound is rendered metabolically low caloric or non-caloric, or a physiologically acceptable ester thereof or a metabolic precursor thereof. The compounds of the invention may be used as fat substitutes, either alone or in combination with other fats or in food compositions, and the like.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Inventors: William J. Wechter, Elaine Benaksas Schwartz, E. David Murray, Israel Gutierrez
  • R-NSAID esters and their use
    Publication number: 20040067914
    Abstract: The present invention concerns esters of R-enantiomers of a non-steroidal anti-inflammatory drug, which is substantially free from the S-enantiomer. The compounds of the invention may be used in treating a disease or illness in a mammal. To this end, a composition comprising a compound mentioned above, or a pharmaceutically acceptable salt thereof where salt formation occurs, is administered to the mammal in an amount sufficient to elicit a chemopreventative effect or a chemoprotective effect or a therapeutic effect or a prophylactic effect.
    Type: Application
    Filed: October 3, 2003
    Publication date: April 8, 2004
    Inventors: William J. Wechter, Elaine Benaksas Schwartz